Clinical Trial Update: QUILT-3.050: NANT Colorectal Cancer (CRC) Vaccine: Combination Immunotherapy in Subjects With Recurrent or Metastatic CRC [Phase 1, Phase 2]

View source ↗

Summary

The NANT Colorectal Cancer vaccine trial (NCT03169777) for recurrent/metastatic colorectal cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• NANT Colorectal Cancer (CRC) Vaccine

Snippet

Sponsor: ImmunityBio, Inc. | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: WITHDRAWN